Nu-med Plus, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OQB
NUMD
Nu-med Plus, INCNu-Med Plus, Inc. reports a strategic pivot towards gold exploration through acquisitions, while continuing to face significant financial headwinds and an uncertain going concern status.
OQB
NUMD
Nu-med Plus, INCNU-MED PLUS, an early-stage medical device company, reported a net loss for Q3 2025 and expressed substantial doubt about its ability to continue as a going concern without significant new capital.
OQB
NUMD
Nu-med Plus, INCNU-MED PLUS, an early-stage medical device company, reported a net loss and significant working capital deficiency, raising substantial doubt about its ability to continue operations without immediate capital infusion.
OQB
NUMD
Nu-med Plus, INCNu-Med Plus, a medical device company, reported no revenue and a net loss of $19,933 for the quarter ended March 31, 2025, highlighting the company's reliance on external funding to continue operations and product development.
OQB
NUMD
Nu-med Plus, INCNu-Med Plus, Inc. reported its third quarter 2024 results, showing no revenue and a net loss, while also announcing the termination of its merger agreement with YourSpace America, Inc.
OQB
NUMD
Nu-med Plus, INCNu-Med Plus reports no revenue and a net loss for the second quarter of 2024, while awaiting the completion of the YourSpace America merger.
OQB
NUMD
Nu-med Plus, INCNu-Med Plus reported a net loss for Q1 2024 and announced a merger with YourSpace America, Inc., which will result in a change of control and a shift in business focus.